Cardiovascular Disease Doctors in Lauderdale Lakes, FL Accepting Medicare

4 Cardiovascular Disease doctors found. Showing 1 - 4

Mr. Richard Barry Polakoff, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4850 W Oakland Park Blvd, Suite 143, Lauderdale Lakes, FL 33313 Phone: 954-676-9980    Fax: 954-676-5288

Dr. Sachil Shah, M.D Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2589 N State Road 7, Lauderdale Lakes, FL 33313 Phone: 954-714-1264

Dr. Bruce Alan Perlman, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3001 Nw 49th Ave, Suite 206, Lauderdale Lakes, FL 33313 Phone: 954-777-2022    Fax: 954-777-2021

Mihaela G Corteza, APRN Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5000 W Oakland Park Blvd, Lauderdale Lakes, FL 33313 Phone: 954-730-2823

News Archive

New study broadens understanding of how the immune system responds to flu virus

A new study of influenza infection in an animal model broadens understanding of how the immune system responds to flu virus, showing that the process is more dynamic than usually described, engaging a broader array of biological pathways. The researchers say their findings may offer key insights for designing more effective vaccines in general.

Obama's health reform political maneuvers may prove successful

"After months of plodding work by five Congressional committees and weeks of back-room bargaining by Democratic leaders, President Obama's arms-length strategy on health care appears to be paying dividends, with the House and the Senate poised to take up legislation to insure nearly all Americans," The New York Times reports.

Amgen to reduce price of Neulasta following Board's orders

The Board issued a Notice of Hearing on March 16, 2009, pertaining to allegations of Board Staff that Neulasta had been, and was being, sold by Amgen Canada Inc. at prices exceeding those indicated by the Board's Excessive Price Guidelines. On October 13, 2009, the Hearing Panel received a Joint Submission by Amgen and Board Staff along with a Voluntary Compliance Undertaking ("VCU") which proposed to resolve the issues raised in the Neulasta proceedings.

Doctoral students receive insights on potential career paths at symposium hosted by Emergent Biosolutions

Emergent BioSolutions Inc.today hosted "Looking Beyond the Bench," a symposium organized for doctoral students enrolled in the NIH-Oxford-Cambridge Scholars Program. The symposium featured Emergent executives, who, based industry, provided insight on potential career paths awaiting biomedical researchers.

Dendrimers offers a new way to treat age-related macular degeneration, retinitis pigmentosa

Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A study by investigators at Mayo Clinic, Wayne State University and Johns Hopkins Medicine shows that steroids attached to the dendrimers target the damage-causing cells associated with neuroinflammation, leaving the rest of the eye unaffected and preserving vision.

Read more Medical News

› Verified 8 days ago